ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992

Bush Signs HHS Appropriations; NCI Budget $4.188B After Administrative Rescission.

January 11, 2002

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991

Avastin Improves PFS For Metastatic Colorectal Cancer In Phase III Study

February 23, 2007

White House Estimates Automatic Budget Cuts Would Take 8.2 Percent From NCI, NIH and FDA

September 21, 2012

EORTC Screening, Pharmacology Group Focuses On CNU

January 2, 1987